Vertex Pharmaceuticals Inc. (VRTX) reported a profit for its first quarter that Increases, from last year
The company's bottom line came in at $1.031 billion, or $4.02 per share. This compares with $646.3 million, or $2.49 per share, last year.
Excluding items, Vertex Pharmaceuticals Inc. reported adjusted earnings of $1.147 billion or $4.47 per share for the period.
The company's revenue for the period rose 7.8% to $2.986 billion from $2.770 billion last year.
Vertex Pharmaceuticals Inc. earnings at a glance (GAAP) :
-Earnings: $1.031 Bln. vs. $646.3 Mln. last year.-EPS: $4.02 vs. $2.49 last year.-Revenue: $2.986 Bln vs. $2.770 Bln last year.
For comments and feedback contact: editorial@rttnews.com
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.